Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (4-benzyl-4-hydroxy-1-piperidinyl)(2,4'-bipyridin-3-yl)methanone
2. Ov-935
3. Ov935
1. Ov935
2. 1429505-03-2
3. Tak-935
4. Soticlestat [inn]
5. Soticlestat [usan]
6. Ov-935
7. Tak935
8. Soticlestat (usan)
9. 1766mu795l
10. (4-benzyl-4-hydroxypiperidin-1-yl)-(2-pyridin-4-ylpyridin-3-yl)methanone
11. [4-oxidanyl-4-(phenylmethyl)piperidin-1-yl]-(2-pyridin-4-ylpyridin-3-yl)methanone
12. Soticlestat [usan:inn]
13. Chembl4298172
14. Schembl14841089
15. Unii-1766mu795l
16. Gtpl11517
17. Who 10844
18. Hy-109123
19. Cs-0078356
20. D11590
21. (4-benzyl-4-hydroxypiperidin-1-yl) (2,4'-bipyridin-3-yl)methanone
22. (4-benzyl-4-hydroxypiperidin-1-yl)(2,4'-bipyridin-3-yl)methanone
23. [2,4'-bipyridin]-3-yl(4-benzyl-4-hydroxypiperidin-1-yl)methanone
24. 2,4'-bipyridin-3-yl(4-benzyl-4-hydroxypiperidin-1-yl)methanone
25. Ybs
| Molecular Weight | 373.4 g/mol |
|---|---|
| Molecular Formula | C23H23N3O2 |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 373.17902698 g/mol |
| Monoisotopic Mass | 373.17902698 g/mol |
| Topological Polar Surface Area | 66.3 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 506 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of Chromosome 15q Duplication Syndrome, Treatment of Cyclin-Dependent Kinase-Like 5 deficiency disorder
Treatment of Dravet syndrome, Treatment of Lennox-Gastaut syndrome
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Soticlestat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Soticlestat, including repackagers and relabelers. The FDA regulates Soticlestat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Soticlestat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Soticlestat supplier is an individual or a company that provides Soticlestat active pharmaceutical ingredient (API) or Soticlestat finished formulations upon request. The Soticlestat suppliers may include Soticlestat API manufacturers, exporters, distributors and traders.
Soticlestat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Soticlestat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Soticlestat GMP manufacturer or Soticlestat GMP API supplier for your needs.
A Soticlestat CoA (Certificate of Analysis) is a formal document that attests to Soticlestat's compliance with Soticlestat specifications and serves as a tool for batch-level quality control.
Soticlestat CoA mostly includes findings from lab analyses of a specific batch. For each Soticlestat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Soticlestat may be tested according to a variety of international standards, such as European Pharmacopoeia (Soticlestat EP), Soticlestat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Soticlestat USP).
LOOKING FOR A SUPPLIER?
